Current Edition


Merck inks deal with China’s Xian Janssen for type 2 diabetes drug

China has more than 114 million people living with diabetes, the largest number of any country in the world Global drug giant, Merck signed an …

Continue Reading →

J&J’s Janssen to Acquire BeneVir for $1 Billion

Janssen Biotech, part of Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson (J&J), announced on May 2, 2018 that it has entered into a …

Continue Reading →